Buchhave, P;
Blennow, K;
Zetterberg, H;
Stomrud, E;
Londos, E;
Andreasen, N;
Minthon, L;
(2009)
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
PLoS One
, 4
(7)
, Article e6294. 10.1371/journal.pone.0006294.
Preview |
PDF
journal.pone.0006294.pdf Download (129kB) |
Abstract
The CSF biomarkers tau and Abeta42 can identify patients with AD, even during the preclinical stages. However, previous studies on longitudinal changes of tau and Abeta42 in individual patients with AD and elderly controls report somewhat inconsistent results.
Type: | Article |
---|---|
Title: | Longitudinal study of CSF biomarkers in patients with Alzheimer's disease |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1371/journal.pone.0006294 |
Publisher version: | http://dx.doi.org/10.1371/journal.pone.0006294 |
Language: | English |
Additional information: | © 2009 Buchhave et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. PMCID: PMC2707615 |
Keywords: | Aged, Aged, 80 and over, Alzheimer Disease, Amyloid beta-Peptides, Biological Markers, Case-Control Studies, Cohort Studies, Female, Humans, Longitudinal Studies, Male, Middle Aged, tau Proteins |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
URI: | https://discovery.ucl.ac.uk/id/eprint/1411805 |
Archive Staff Only
View Item |